Update 1–U.S. FDA Finds Peeling Paint, Debris at U.S. Plant Making J&J’s COVID-19 Vaccine

April 23, 2021

(Medscape) – A U.S. plant that was making Johnson & Johnson’s COVID-19 vaccine must fix a long list of problems including peeling paint and unsanitary conditions and practices to resume operation, according to a highly critical report by the Food and Drug Administration. Experts said addressing the issues raised in the scathing FDA inspection report could take months.